Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook
HAIFA, Israel, Feb. 13, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments for the second …